Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Clinical trial NCT01799993 · COMPLETED
Trial details
- NCT number
- NCT01799993
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-13
- Primary completion
- 2017-04-07
- Enrollment
- 725
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.